InfuSystem (NYSE: INFU) revenue
InfuSystem reported revenue of $143.4m for fiscal 2025, 6.4% more than in fiscal 2024 ($134.9m). Since fiscal 2016 its revenue has grown by 103.5%, an average growth of 8.2% a year.
InfuSystem has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2018, −5.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $143.4m | +6.4% | $11.9m | 8.3% |
| 2024 | $134.9m | +7.2% | $6.9m | 5.1% |
| 2023 | $125.8m | +14.4% | $4.1m | 3.2% |
| 2022 | $109.9m | +7.4% | $1.7m | 1.5% |
| 2021 | $102.4m | +5.1% | $2.8m | 2.8% |
| 2020 | $97.4m | +20.1% | $8.8m | 9.1% |
| 2019 | $81.1m | +20.8% | $3.5m | 4.3% |
| 2018 | $67.1m | −5.5% | $0.4m | 0.6% |
| 2017 | $71.1m | +0.8% | −$3.8m | −5.4% |
| 2016 | $70.5m | — | $1.0m | 1.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
InfuSystem revenue compared with its sector
By revenue for its latest fiscal year, InfuSystem ranks 266th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; InfuSystem, 6.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 264th | Grail | $147.2m | 17.2% |
| 265th | Karyopharm Therapeutics | $146.1m | 0.6% |
| 266th | InfuSystem | $143.4m | 6.4% |
| 267th | Beam Therapeutics | $139.7m | 120.0% |
| 268th | SPOK | $139.7m | 1.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of InfuSystem
- How much revenue did InfuSystem make in fiscal 2025?
- InfuSystem reported revenue of $143.4m for fiscal 2025, compared with $134.9m in fiscal 2024.
- How much has the revenue of InfuSystem grown?
- Between fiscal 2016 and fiscal 2025 it went from $70.5m to $143.4m: 103.5% more, an average growth of 8.2% a year.
- What was the best year for revenue at InfuSystem?
- Of its last 10 fiscal years, fiscal 2025, with $143.4m.
- Where does InfuSystem rank in its sector by revenue?
- It ranks 266th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for InfuSystem come from?
- From the annual report (Form 10-K) that InfuSystem files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that InfuSystem files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on InfuSystem: the InfuSystem page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.